Patient Consent Forms May Be Redesigned To Permit Broader Data Release
Genentech is considering seeking broader authorizations for data when patients sign up for clinical trials that would allow for use of the data beyond the scope of the trials.
You may also be interested in...
HHS final privacy regulations specify that manufacturers can receive disclosures of protected health information from healthcare providers without patient consent only when the disclosure is made to an authorized employee for collection activities under specific FDA direction or requirement.
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials